PRMEDICA brings the best neuroregenerative treatment for Alzheimer's, Parkinson's, nerve damage and neuropathies. The treatment aims to cure chronic, neurodegenerative and idiopathic condition like Alzheimer's or neurological disorder with evolving layers of complexity like Parkinson's.
There are clinical challenges associated with such diseases including the inability to make a proper diagnosis during the earliest stages of the difficulties and diseases. Thus, managing the symptoms at the later stages also becomes challenging.
At PRMEDICA, the main objective of neuroregenerative treatment is to promote tissue regeneration and repair damage done because of the disease's progressive nature. PRMEDICA experts achieve this with the stem cells' tissue regeneration properties in conjunction with exosomes' growth factors and the anti-inflammatory biomolecules. The combination of stem cells and exosomes promotes neuronal survivability, stimulate neuronal stem cells and reduce brain inflammation.
The treatment has additional objectives that aims to increase the quality of life by improving general metabolic functions of the patients. This is done through a combination of therapies that increase the amount of cell oxygen intake, fulfill the body´s requirements of minerals, vitamins, and antioxidants, and cleanse the blood-flow of calcium plaque, oxidative stress, free radical levels and heavy metal buildup.
The neuroprotective properties of mesenchymal stem cells (MSCs) and MSCs exosomes inhibit neuroinflammation, increase neurogenesis, enhance neurite remodeling, increase cell proliferation and improve neurological function.
Intrathecal injection with 3 ml. purified placental mesenchymal exosomes, 75 million placental mesenchymal stem cells + 10 ml. purified placental mesenchymal exosomes IV infusion and bloodwork.
Intrathecal injection with 3 ml. purified placental mesenchymal exosomes, 125 million placental mesenchymal stem cells + 15 ml. purified placental mesenchymal exosomes IV infusion and bloodwork.
Intrathecal injection with 3 ml. purified placental mesenchymal exosomes, 150 million placental mesenchymal stem cells + 15 ml. purified placental mesenchymal exosomes IV infusion and bloodwork.
For more information on Full Neuroregenerative Treatment at PRMEIDICA in Cabo, Mexico, click the button below!